Management of inflammatory bowel disease (IBD) during the COVID-19 pandemic
Timely expert recommendations regarding the management of patients with inflammatory bowel disease (IBD) during the coronavirus pandemic.
Role of probiotics in the management of gastrointestinal disorders
Find out if probiotics are recommended, and if so what strains, for specific GI conditions. This guideline covers C. difficile infection, adults and children on antibiotic treatment, Crohn’s disease, ulcerative colitis, pouchitis, irritable bowel syndrome (IBS), acute infectious gastroenteritis, and preterm/low-birth-weight infants.
Diagnosis and management of small intestinal bacterial overgrowth (SIBO)
A detailed review of small intestinal bacterial overgrowth (SIBO).
Gastrointestinal evaluation of iron deficiency anemia
Treatment protocol for the initial diagnosis and GI evaluation of iron deficiency anemia (IDA).
Management of inflammatory bowel disease (IBD) in elderly patients
Advice for handling the unique challenges that come with diagnosis and therapeutic decision making in elderly patients with inflammatory bowel disease (IBD) (Crohn’s disease or ulcerative colitis).
Evaluation and management of seronegative enteropathies
Steps for diagnosing and managing patients with suspected enteropathy, but negative results from serologic tests for celiac disease (seronegative enteropathy).
Diagnosis and management of immune checkpoint inhibitor colitis and hepatitis
An update on the GI and hepatic toxicities of immune checkpoint inhibitors (ICIs) and best practice advice on their diagnosis and management.
Medical management of colonic diverticulitis
Practical and evidence-based advice for the management of diverticulitis.
Medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease
How to select the best drug therapy for your patients with moderate-to-severe luminal and fistulizing Crohn’s disease.
Management of chronic gastrointestinal pain in disorders of gut-brain interaction
Approaches to best manage pain in disorders of gut-brain interaction.
